Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)

HKD 1.16

(0.0%)

Net Income Summary of Dawnrays Pharmaceutical (Holdings) Limited

  • Dawnrays Pharmaceutical (Holdings) Limited's latest annual net income in 2023 was 326 Million CNY , down -8.95% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited's latest quarterly net income in 2023 FY was 326 Million CNY , down -8.95% from previous quarter.
  • Dawnrays Pharmaceutical (Holdings) Limited reported an annual net income of 358.05 Million CNY in 2022, down -0.03% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited reported an annual net income of 358.17 Million CNY in 2021, up 33.58% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a quarterly net income of 255.94 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a quarterly net income of 70.05 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Historical Annual Net Income of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Year Net Income Net Income Growth
2023 326 Million CNY -8.95%
2022 358.05 Million CNY -0.03%
2021 358.17 Million CNY 33.58%
2020 268.13 Million CNY 4.97%
2019 255.43 Million CNY -15.97%
2018 303.96 Million CNY 3.75%
2017 292.97 Million CNY 10.18%
2016 265.91 Million CNY -12.01%
2015 302.19 Million CNY 47.31%
2014 205.14 Million CNY 33.99%
2013 153.09 Million CNY 33.7%
2012 114.5 Million CNY -21.74%
2011 146.3 Million CNY -12.31%
2010 166.84 Million CNY 40.93%
2009 118.38 Million CNY 16.02%
2008 102.03 Million CNY 0.87%
2007 101.15 Million CNY 53.55%
2006 65.87 Million CNY -37.68%
2005 105.7 Million CNY 31.85%
2004 80.17 Million CNY -25.78%
2003 108.02 Million CNY 7.89%
2002 100.11 Million CNY 0.0%

Peer Net Income Comparison of Dawnrays Pharmaceutical (Holdings) Limited

Name Net Income Net Income Difference
Pak Fah Yeow International Limited 105.03 Million HKD -210.361%
Grand Pharmaceutical Group Limited 1.87 Billion HKD 82.66%
Extrawell Pharmaceutical Holdings Limited -162.94 Million HKD 300.063%
Wai Yuen Tong Medicine Holdings Limited -15.35 Million HKD 2222.949%
Qianhai Health Holdings Limited -52.7 Million HKD 718.537%
Lee's Pharmaceutical Holdings Limited 16.69 Million HKD -1852.33%
Essex Bio-Technology Limited 275.25 Million HKD -18.434%
Tongfang Kontafarma Holdings Limited -28.84 Million HKD 1230.257%
PuraPharm Corporation Limited -106.08 Million HKD 407.312%
SSY Group Limited 1.31 Billion HKD 75.277%
JBM (Healthcare) Limited 130.46 Million HKD -149.879%
Jacobson Pharma Corporation Limited 266.96 Million HKD -22.112%
China Resources Pharmaceutical Group Limited 3.85 Billion HKD 91.542%